These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

470 related items for PubMed ID: 18674421

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition.
    Leiter LA, Lewanczuk RZ.
    Am J Hypertens; 2005 Jan; 18(1):121-8. PubMed ID: 15691626
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Protection of pancreatic beta-cells: is it feasible?
    Bonora E.
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
    [Abstract] [Full Text] [Related]

  • 6. The potential biological mechanisms of arsenic-induced diabetes mellitus.
    Tseng CH.
    Toxicol Appl Pharmacol; 2004 Jun 01; 197(2):67-83. PubMed ID: 15163543
    [Abstract] [Full Text] [Related]

  • 7. Reactive species and early manifestation of insulin resistance in type 2 diabetes.
    Fridlyand LE, Philipson LH.
    Diabetes Obes Metab; 2006 Mar 01; 8(2):136-45. PubMed ID: 16448517
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The use of vitamin E in type 2 diabetes mellitus.
    Fardoun RZ.
    Clin Exp Hypertens; 2007 Apr 01; 29(3):135-48. PubMed ID: 17497341
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Beta-cell function and mass in type 2 diabetes.
    Larsen MO.
    Dan Med Bull; 2009 Aug 01; 56(3):153-64. PubMed ID: 19728971
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Islet redox stress: the manifold toxicities of insulin resistance, metabolic syndrome and amylin derived islet amyloid in type 2 diabetes mellitus.
    Hayden MR, Tyagi SC.
    JOP; 2002 Jul 01; 3(4):86-108. PubMed ID: 12110767
    [Abstract] [Full Text] [Related]

  • 14. Antioxidant drugs for treating beta-cell oxidative stress in type 2 diabetes: glucose-centric versus insulin-centric therapy.
    Robertson RP.
    Discov Med; 2010 Feb 01; 9(45):132-7. PubMed ID: 20193639
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Role of oxidative stress in diabetic bone disorder.
    Hamada Y, Fujii H, Fukagawa M.
    Bone; 2009 Jul 01; 45 Suppl 1():S35-8. PubMed ID: 19232402
    [Abstract] [Full Text] [Related]

  • 20. Oxidative stress: the vulnerable beta-cell.
    Lenzen S.
    Biochem Soc Trans; 2008 Jun 01; 36(Pt 3):343-7. PubMed ID: 18481954
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.